HI
EDIT icon

HBK Investments’s Editas Medicine EDIT Stock Holding History

HBK Investments’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40,000
Closed -$329K – 302
2023
Q2 		$329K Buy
+40,000
New +$348K ﹤0.01% 350
2018
Q2 		– Sell
-14,193
Closed -$470K – 1057
2018
Q1 		$470K Buy
+14,193
New +$506K ﹤0.01% 779

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBK Investments's EDIT Position: Q3 2023 in Review

HBK Investments sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 40,000 shares — an estimated $329K sold.

HBK Investments first reported a position in EDIT in Q1 2018 and held it in 2 quarters. The position peaked at $470K in Q1 2018. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

  • HBK Investments reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
  • HBK Investments sold 40,000 Editas Medicine shares in Q3 2023, an estimated $329K.
  • HBK Investments first reported a position in Editas Medicine in Q1 2018 and held it in 2 quarters.
  • HBK Investments's Editas Medicine position peaked at $470K in Q1 2018.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.